Precious Metals Investing NevGold Announces Up to 85% Antimony Recovery From Positive Phase II Metallurgical Testwork at Oxide Gold-Antimony Limo Butte Project in Nevada
Precious Metals Investing NevGold Discovers High-Grade Oxide Antimony "Bullet Zone" From Surface with 2025 Step-Out Drilling: 14.90 g/t AuEq Over 4.6 Meters Within 2.42 g/t AuEq Over 53.3 Meters at Limo Butte, Nevada
Precious Metals Investing NevGold Releases Significant Oxide Gold-Antimony Results: 11.41 g/t AuEq Over 6.1 Meters Within 2.19 g/t AuEq Over 56.4 Meters at the Limousine Butte Project, Nevada
Precious Metals Investing NevGold Announces Updated Open-Pit, Heap-Leach Gold Mineral Resource Including 1,186,000 ozs Indicated and 548,000 ozs Inferred At Nutmeg Mountain in Idaho
Precious Metals Investing NevGold Starts Drilling And Identifies Additional Stibiconite Outcrops at Gold-Antimony Limo Butte Project
Precious Metals Investing NevGold Announces Up to 92% Antimony Recovery From Positive Metallurgical Testwork Program at Oxide Gold-Antimony Limo Butte Project in Nevada
Precious Metals Investing NevGold Releases Some of the Highest Grade Oxide Gold-Antimony Results To Date: 9.68 g/t AuEq Over 11.6 Meters Within 2.85 g/t AuEq Over 60.3 Meters at the Limousine Butte Project, Nevada
Gold Investing NevGold Extends Oxide Gold-Antimony Mineralization Over 1.7 Kilometers at Cadillac Valley Target: 2.28 g/t AuEq Over 30.5 Meters Within 1.61 g/t AuEq Over 61.0 Meters
Gold Investing NevGold Adds More Significant Oxide Gold-Antimony Results: 7.04 g/t AuEq Over 15.2 Meters Within 4.14 g/t AuEq Over 29.0 Meters , and Expands Gold-Antimony Mineralization Over 400 Meters Along Strike at the Limousine Butte Project, Nevada
Gold Investing NevGold Adds More Significant Oxide Gold-Antimony Results: 1.47 g/t AuEq Over 74.7 Meters , Including 3.59 g/t AuEq Over 18.2 Meters , and Also Including 4.61 g/t AuEq Over 6.0 Meters at the Limousine Butte Project, Nevada
LaFleur Minerals Announces Brokered Private Placement of Gold-Linked Convertible Notes to Finance Restart of Gold Production at Beacon Gold Mill
Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases
